Everybody 12 /Case Studies 0 /Conferences 10 /FreeMind Elite 0 /FreeMind Elite 2024 0 /Job posting 0 /NDFS 2025 Presentations 0 /News 1 /Opinions 0 /Opportunities 1 /Presentations 0 /Uncategorized 0 /Webinars 1
Non-dilutive funding leads to equity investment

How Non-Dilutive Funding Leads to Equity Investment: The Story of Enalare

August 29, 2022/by Ayal Ronen
BioFuture, November 7-9, 2022, NYC

Biofuture, a Demy-Colton Event

August 2, 2022/by Ayal Ronen
HealthTech Investment Forum, September 20-22, 2022, in Basel

The HealthTech Investment Forum & Biotech in Europe Forum, Sept. 20-22, Basel

July 20, 2022/by Ayal Ronen

Advanced Therapies Europe, Aug. 31-Sept. 1, London

July 14, 2022/by Ayal Ronen
Redefining Early Stage Funding Conference, Boston, September 21-23

RESI Boston, Sept. 21-23

July 4, 2022/by Ayal Ronen
MEDFIT 2022 Sept 20-21 Grenoble France

MedFIT, Sept. 21-22, Grenoble, France

July 3, 2022/by Ayal Ronen
LSX Nordic September 6-7, 2022, In-Person in Copenhagen

LSX Nordic Congress, Sept. 2022 (Copenhagen)

July 3, 2022/by Ayal Ronen

Kisaco Onco Cell Therapy Summit, June 29-30, 2022 (Boston)

May 2, 2022/by Ayal Ronen
immuno-oncology innovation forum, May 24-25, 2022, by Sachs Associates

Immuno-Oncology Innovation Forum, May 24-25, 2022 (online)

April 28, 2022/by Ayal Ronen
Digital RESI June 7-9, 2022

Digital RESI, June 7-9, 2022 (online)

April 28, 2022/by Ayal Ronen
LSX World Congress USA 2022 June 21-22

LSX World Congress USA, June 21-22, 2022 (Boston)

April 28, 2022/by Ayal Ronen
$7.245 Billion in Funding Opportunities for Cancer Research. Join our webinar to fund out more.

Webinar: $7+ Billion in Cancer Research Funding Opportunities 2022

April 20, 2022/by Ayal Ronen

Recent Posts

Followon XSubscribeto RSS Feed

Reach out to us with your non-dilutive funding requirements

Skip to content